Clinical ResearchInterventional CardiologyTriple Therapy With Aspirin, Prasugrel, and Vitamin K Antagonists in Patients With Drug-Eluting Stent Implantation and an Indication for Oral Anticoagulation
Interventional Cardiology
Under an Elsevier user license
open archive
Key Words
aspirin
clopidogrel
drug-eluting stent(s)
high platelet reactivity
prasugrel
vitamin K antagonist
Abbreviations and Acronyms
ADP
adenosine diphosphate
AU
arbitrary units
CI
confidence interval
DES
drug-eluting stent(s)
HPR
high platelet reactivity
HR
hazard ratio
INR
international normalized ratio
MACCE
major adverse cardiac and cerebrovascular ischemic event(s)
OAC
oral anticoagulation
PCI
percutaneous coronary intervention
TIMI
Thrombolysis In Myocardial Infarction
Cited by (0)
Dr. Sibbing is a consultant for Verum Diagnostica; and receives payment for lectures from Eli Lilly and Daiichi Sankyo. Dr. Mehilli has received lecture fees from Lilly/Daiichi Sankyo, AstraZeneca, Abbott Vascular, and Terumo. Dr. Kastrati has received payment for lectures from AstraZeneca, Daiichi Sankyo, and Eli Lilly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.